RNO 0.00% 4.0¢ rhinomed limited

Ann: Rhinoswab junior clinical trial results, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 929 Posts.
    lightbulb Created with Sketch. 205
    There is definitely some merit in the posts since Xmas.

    RNO can't get a much better chance than this to advance.

    There was so much goodwill and media coverage (including the Vic Government press release) for the Junior when the trial was announced, that it's hard to imagine that it has simply evaporated, especially given the decent results.

    Three Directors putting in $1.7m less than 2 weeks ago at approximately these prices, should steady nerves this side of announcements.


 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.